Recent Insider Transactions - Intellia Therapeutics (NASDAQ: NTLA)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ NTLA Intellia Therapeutics

Schultes Birgit C / officer: EVP, Chief Scientific Officer

10/01/2025

Sell

$17.38

$539

105,184

NASDAQ NTLA Intellia Therapeutics

Dube Michael P / officer: VP, Chief Accounting Officer

10/01/2025

Sell

$17.38

1,871

$33K

55,266

NASDAQ NTLA Intellia Therapeutics

CHASE WILLIAM J / director

08/20/2025

Buy

$10.03

100,000

$1.003M

134,693